RxDoctor Payments Data

Carlos Rodriguez, MD

General Practice · Miami, FLNPI 1093864548

Payments from drug & device makers

$169in general payments, 2019–2025

Across 8 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$48
  • Vapotherm Inc$25
  • Portola Pharmaceuticals, LLC$23
  • Insulet Corporation$21
  • Bristol Myers Squibb$20
  • Shield Therapeutics Inc$19
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$169100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$169 in reported general payments places this provider in the 35th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$71,974
Medicare patients
131
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban298$101,749
GemtesaVibegron79$19,267
LinzessLinaclotide25$17,460
JanuviaSitagliptin Phosphate33$16,969
TradjentaLinagliptin56$16,467
JardianceEmpagliflozin46$16,276
TrulicityDulaglutide42$13,951
ArexvyRsvpref3 Antigen/As01e/Pf34$10,323
XareltoRivaroxaban28$8,987
RetacritEpoetin Alfa-Epbx17$7,614
Incruse ElliptaUmeclidinium Bromide16$6,051
Advair HfaFluticasone Propion/Salmeterol15$5,737
Rosuvastatin Calcium217$5,270
Levothyroxine Sodium316$5,144
Budesonide33$4,317

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$14$8,98728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 6,901 general practice providers in Florida.

Other general practice in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →